Biliary Tract Cancer

Biliary tract cancer or cholangiocarcinoma is one of the types of cancer of the digestive system and is also one of the types of hepatobiliopancreatic tumors (liver, pancreas, and bile ducts).

Biliary tract cancer or cholangiocarcinoma is one of the types of cancer of the digestive system and is also one of the types of hepatobiliopancreatic tumors (liver, pancreas, and bile ducts). It occurs mainly in people over 50 years of age, although it can occur at any age.

Cancer can develop anywhere in the bile duct and, based on its location, is classified into three types:

  • Intrahepatic cholangiocarcinoma;
  • Perihilar cholangiocarcinoma: Being the most common type of cholangiocarcinoma, accounting for more than half of all cancers of the bile duct;
  • Distal cholangiocarcinoma;

Cholangiocarcinoma can also be divided into types, based on the appearance of the cancer cells under the microscope. Over 95% of cancers of the bile duct are carcinomas and the majority are adenocarcinomas.

There are several treatment options for cholangiocarcinoma, including surgery, radiotherapy, locoregional therapies, chemotherapy, targeted therapy, immunotherapy, or palliative therapy.
However, it is essential to get a second opinion for this cancer, as it is uncommon cancer like cholangiocarcinoma, as for any other. A second opinion can provide more information and help you feel more confident about your chosen treatment plan.


Biliary Tract Cancer Studies

Locations



Biliary Cancer Cancer Studies

Details

There are several studies available, here are some of the ones you can find:

Status Study Conditions Interventions Locations
Recruiting Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC) Biliary Tract Cancer Drug: Nivolumab
Drug: DKN-01
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting Molecular Profiling of Advanced Biliary Tract Cancers Biliary Tract Cancer Other: Tumour and germline molecular profiling
  • McGill University Health Centre
    Montréal, Quebec, Canada
Recruiting Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer Biliary Tract Cancer
  • Arizona Oncology Associates , PC – HOPE
    Tucson, Arizona, United States
    University of Arizona Cancer Center
    Tucson, Arizona, United States
    The Oncology Institute of Hope and Innovation
    Whittier, California, United States
    (and 122 more…)
Not yet recruiting Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer Biliary Tract Cancer Drug: Cisplatin
Drug: Gemcitabine
Drug: Oxaliplatin
(and 2 more…)
Recruiting Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer Biliary Tract Cancer Drug: mFOLFOX6, Atezolizumab and Bevacizumab Universitätsklinikum Essen
Essen, NRW, Germany
Clínica Universidad de Navarra
Pamplona, Spain
Not yet recruiting A Trial of SHR1258 in Patients With Biliary Tract Cancer Biliary Tract Cancer
  • Drug: SHR1258
Not yet recruiting A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer Biliary Tract Cancer Drug: ZKAB001 5mg/kg
Drug: Capecitabine
Not yet recruiting Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer Biliary Tract Cancer Drug: Gemcitabine/Capecitabine
Drug: Capecitabine
Unknown Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer Biliary Tract Cancer
  • Drug: Docetaxel, Oxaliplatin
  • Eun Ki Song
    Chonbuk, Korea, Republic of
Recruiting Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Biliary Tract Cancer
  • Drug: CPI 613
    Drug: Gemcitabine
    Drug: Cisplatin
  • University of Arizona Cancer Center
    Tucson, Arizona, United States
    Northwestern University — Lurie Comprehensive Cancer Center
    Chicago, Illinois, United States
    University of Michigan Rogel Cancer Center
    Ann Arbor, Michigan, United States
    (and 6 more…)



New Breathe

WE CARE, WE CAN





New Breathe

WE CARE, WE CAN




0-800-777-2331


24/7 EMERGENCY NUMBER

Call us now if you are in a medical emergency need, we will reply swiftly and provide you with a medical aid.




2021 © New Breathe. Powered with by Goweb Agency.



2021 © New Breath. Powered with by Goweb Agency.